Study of the Efficacy and Safety of the Drug Ingaron (Interferon-gamma) in the Treatment of Anogenital Warts

Clinical trial NCT05156541 · COMPLETED

Trial details

NCT number: NCT05156541
Sponsor: SPP Pharmaclon Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Human Papillomavirus Infection Anogenital Warts

Start date: 2009-05-18
Primary completion: 2010-06-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.